cabozantinib (XL184)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cabozantinib (XL184), covering 2013-09-19 to 2013-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors [Phase 1]